RS58381B1 - Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora - Google Patents
Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitoraInfo
- Publication number
- RS58381B1 RS58381B1 RS20190228A RSP20190228A RS58381B1 RS 58381 B1 RS58381 B1 RS 58381B1 RS 20190228 A RS20190228 A RS 20190228A RS P20190228 A RSP20190228 A RS P20190228A RS 58381 B1 RS58381 B1 RS 58381B1
- Authority
- RS
- Serbia
- Prior art keywords
- addiction
- impulse
- treatment
- control disorders
- pde7 inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Addiction (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261643611P | 2012-05-07 | 2012-05-07 | |
US13/835,607 US9220715B2 (en) | 2010-11-08 | 2013-03-15 | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
PCT/US2013/039866 WO2013176877A2 (en) | 2012-05-07 | 2013-05-07 | Treatment of addiction and impulse-control disorders using pde7 inhibitors |
EP13793319.8A EP2846805B1 (en) | 2012-05-07 | 2013-05-07 | Treatment of addiction and impulse-control disorders using pde7 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
RS58381B1 true RS58381B1 (sr) | 2019-04-30 |
Family
ID=49624481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20190228A RS58381B1 (sr) | 2012-05-07 | 2013-05-07 | Lečenje zavisnosti i poremećaja kontrole impulsa upotrebom pde7 inhibitora |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP2846805B1 (sr) |
JP (1) | JP2015521177A (sr) |
CN (3) | CN104768556A (sr) |
AU (1) | AU2013266793B2 (sr) |
CA (1) | CA2871151C (sr) |
IN (1) | IN2014DN10404A (sr) |
PL (1) | PL2846805T3 (sr) |
RS (1) | RS58381B1 (sr) |
SI (1) | SI2846805T1 (sr) |
WO (1) | WO2013176877A2 (sr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130124333A (ko) | 2010-11-08 | 2013-11-13 | 오메로스 코포레이션 | Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료 |
US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
CN109937038A (zh) * | 2016-08-26 | 2019-06-25 | 田边三菱制药株式会社 | 双环式含氮杂环化合物 |
WO2023243659A1 (ja) * | 2022-06-15 | 2023-12-21 | 真一 松本 | 線条体ストリオソームのドパミンd1シグナルを標的とした強迫性障害の薬物療法 |
WO2024038089A1 (en) | 2022-08-18 | 2024-02-22 | Mitodicure Gmbh | Use of a therapeutic agent with phosphodiesterase-7 inhibitory activity for the treatment and prevention of diseases associated with chronic fatigue, exhaustion and/or exertional intolerance |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102827082B (zh) * | 2004-07-01 | 2015-01-07 | 第一三共株式会社 | 具有pde7抑制活性的噻吩并吡唑衍生物 |
US20060183763A1 (en) * | 2004-12-31 | 2006-08-17 | Pfizer Inc | Novel pyrrolidyl derivatives of heteroaromatic compounds |
CA2623072A1 (en) * | 2005-09-26 | 2007-04-05 | Avigen, Inc. | Use of ibudilast for treating drug and behavioral addictions |
US20080260643A1 (en) * | 2007-03-27 | 2008-10-23 | Omeros Corporation | Use of pde7 inhibitors for the treatment of movement disorders |
US8637528B2 (en) * | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
AU2008240158B2 (en) * | 2007-04-11 | 2014-07-10 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
FR2943673B1 (fr) * | 2009-03-27 | 2013-03-29 | Sanofi Aventis | Applications therapeutiques de derives de quinazolinedione |
FR2944282B1 (fr) * | 2009-04-09 | 2013-05-03 | Sanofi Aventis | Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques |
KR20130124333A (ko) * | 2010-11-08 | 2013-11-13 | 오메로스 코포레이션 | Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료 |
-
2013
- 2013-05-07 EP EP13793319.8A patent/EP2846805B1/en active Active
- 2013-05-07 JP JP2015511605A patent/JP2015521177A/ja active Pending
- 2013-05-07 CA CA2871151A patent/CA2871151C/en active Active
- 2013-05-07 IN IN10404DEN2014 patent/IN2014DN10404A/en unknown
- 2013-05-07 AU AU2013266793A patent/AU2013266793B2/en active Active
- 2013-05-07 CN CN201380036048.1A patent/CN104768556A/zh active Pending
- 2013-05-07 RS RS20190228A patent/RS58381B1/sr unknown
- 2013-05-07 CN CN202210569437.1A patent/CN114984229A/zh active Pending
- 2013-05-07 WO PCT/US2013/039866 patent/WO2013176877A2/en active Application Filing
- 2013-05-07 SI SI201331354T patent/SI2846805T1/sl unknown
- 2013-05-07 CN CN202011054538.2A patent/CN112168972A/zh active Pending
- 2013-05-07 PL PL13793319T patent/PL2846805T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013176877A3 (en) | 2015-06-18 |
EP2846805B1 (en) | 2018-11-21 |
CN114984229A (zh) | 2022-09-02 |
IN2014DN10404A (sr) | 2015-08-14 |
AU2013266793B2 (en) | 2016-08-04 |
JP2015521177A (ja) | 2015-07-27 |
CA2871151A1 (en) | 2013-11-28 |
CA2871151C (en) | 2019-03-26 |
SI2846805T1 (sl) | 2019-04-30 |
CN112168972A (zh) | 2021-01-05 |
CN104768556A (zh) | 2015-07-08 |
EP2846805A4 (en) | 2016-08-10 |
EP2846805A2 (en) | 2015-03-18 |
AU2013266793A1 (en) | 2014-11-27 |
PL2846805T3 (pl) | 2019-05-31 |
WO2013176877A2 (en) | 2013-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261768B (en) | Devices and methods for tissue treatment | |
EP2640395A4 (en) | TREATMENT OF DISEASES ASSOCIATED WITH SEARCH AND PULSE CONTROL BY PDE7 INHIBITORS | |
HRP20171352T1 (hr) | Wnt-antagonisti i postupci liječenja | |
HK1205938A1 (en) | Inhibitors of human ezh2, and methods of use thereof ezh2 | |
EP2887805A4 (en) | COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE | |
SG11201504022RA (en) | Glutamase inhibitors and method of use | |
HK1207968A1 (en) | Usp30 inhibitors and methods of use usp30 | |
EP2844271A4 (en) | PROCESSING METHOD AND AGENTS USEFUL THEREFOR | |
GB201217296D0 (en) | Method of treatment and/or prevention | |
IL280144A (en) | Use of telomerase inhibitors to treat bone marrow culture disorders and bone marrow culture tumors | |
EP2852397A4 (en) | HUWENTOXIN IV VARIANTS AND METHODS OF USE | |
HK1206282A1 (en) | Tfpi inhibitors and methods of use tfpi | |
EP2694079A4 (en) | POLYMERS AND METHOD FOR PAIN TREATMENT | |
ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
EP2825173A4 (en) | CALMODULIN INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISEASES AND RIBOSOMAPATHIES | |
ZA201501503B (en) | Bio-inoculant and use thereof for treatment of effluents | |
PL2846805T3 (pl) | Leczenie uzależnień i zaburzeń kontroli impulsów za pomocą inhibitorów PDE7 | |
EP2681209A4 (en) | COMPOUNDS AND METHODS FOR TREATING PAIN AND OTHER DISEASES | |
HRP20190279T1 (hr) | Liječenje ovisnosti i poremećaja nagona pomoću pde7 inhibitora | |
EP2825184A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN | |
GB201101688D0 (en) | Treatment of porous structire and device therefor |